リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「The effects of maternal polyphenol intake during lactation on lipid metabolism in adult rat offspring」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

The effects of maternal polyphenol intake during lactation on lipid metabolism in adult rat offspring

山﨑, 尚二郎 北海道大学

2021.03.25

概要

Lipids, along with carbohydrates and proteins, are irreplaceable nutrients for humans. In the human body, various lipids including triglyceride (TG), fatty acid (FA), and cholesterol exist and play crucial roles such as storing energy, signaling, and acting as structural components of cell membranes (Fahy et al. 2009; Subramaniam et al. 2011). Lipid is strictly controlled its homeostasis in the body due to the importance and variety of its function. Lipid homeostasis imbalance, in other words, lipid metabolic disorders are often found as obesity, overweight, hyperlipidemia, and non-alcoholic fatty liver diseases (NAFLD). For adults, World Health Organization (WHO) defines overweight is a body mass index (BMI) greater than or equal to 25 and obesity is a BMI greater than or equal to 30. And WHO estimated that 39% of the world’s adult (18 years and older) population is overweight and 13% is obese in 2016, meaning more than 1.9 billion adults are overweight, of whom 650 million are obese. And prevalence of obesity nearly tripled between 1975 and 2016 (WHO 2020). NAFLD exists on a spectrum from simple fatty liver to an inflamed fatty liver (non-alcoholic steatohepatitis; NASH) (Ludwig et al. 1980; Schaffner & Thaler 1986; Younossi et al. 1998). The global prevalence of NAFLD in the general population has been estimated to be 25% and the global prevalence of NASH has been estimated to range from 3% to 5% (Vernon et al. 2011; Younossi et al. 2016; Younossi et al. 2018). These data indicate that lipid metabolic disorders are now globally common diseases.

Studies have indicated that lipid metabolic disorders are risk factors for noncommunicable diseases (NCDs) and can progress to severe diseases. The main types of NCDs are cardiovascular diseases (CVDs), cancers, chronic respiratory diseases and diabetes mellitus (DM). Currently, NCDs are one of the most serious health issues. WHO estimated that NCDs caused 70% of all deaths in 2016 (WHO 2018). Studies have reported a relationship between hypercholesterolemia and deaths caused by CVDs, indicating that hypercholesterolemia is a risk factor of CVDs (Kannel et al. 1986; Chen et al. 1991; Stamler et al. 2000; Emberson et al. 2003; Grau et al. 2010; Imano et al. 2011; Sugiyama et al. 2015). NAFLD, especially NASH is reported that it can progress to more serious disease stages, such as advanced fibrosis, cirrhosis, liver failure, or liver cancer (Powell et al. 1990; Angulo 2002; Vernon et al. 2011; Torres et al. 2012; McPherson et al. 2015). Global age-standardized prevalence in 2017 was estimated 11.061 cases per 100 000 for cirrhosis due to NASH and 1.20 cases per 100 000 for liver cancer due to NASH (James et al. 2018). Moreover, studies have reported the close relationship between obesity or overweight and DM and its risk factor, insulin resistance (Wagenknecht et al. 2003; Kahn et al. 2006).

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

Angulo P. 2002. Nonalcoholic Fatty Liver Disease. N Engl J Med. 346:1221–1231. doi: 10.1056/NEJMra011775

Armitage JA, Taylor PD, Poston L. 2005. Experimental models of developmental programming: Consequences of exposure to an energy rich diet during development. J Physiol. 565:3–8. doi: 10.1113/jphysiol.2004.079756

Barker DJP. 1990. The fetal and infant origins of adult disease. Br Med J. 301:1111. doi: 10.1136/bmj.301.6761.1111

Barker DJP. 2007. The origins of the developmental origins theory. In: J Intern Med. 261: 412–417. doi: 10.1111/j.1365-2796.2007.01809.x

Bravo L. 2009. Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance. Nutr Rev. 56:317–333. doi: 10.1111/j.1753-4887.1998.tb01670.x

Brookins Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS. 2009. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med. 46:1589–1597. doi: 10.1016/j.freeradbiomed.2009.03.011

Catalano PM, Ehrenberg HM. 2006. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG An Int J Obstet Gynaecol. 113:1126–1133. doi: 10.1111/j.1471-0528.2006.00989.x

Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. 1991. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. Br Med J. 303:276–282. doi: 10.1136/bmj.303.6797.276

Crozier A, Jaganath IB, Clifford MN. 2009. Dietary phenolics: Chemistry, bioavailability and effects on health. Nat Prod Rep. 26:1001–1043. doi: 10.1039/b802662a

Dai J, Mumper RJ. 2010. Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties. Molecules. 15:7313–7352. doi: 10.3390/molecules15107313

Ehara T, Kamei Y, Takahashi M, Yuan X, Kanai S, Tamura E, Tanaka M, Yamazaki T, Miura S, Ezaki O, et al. 2012. Role of DNA methylation in the regulation of lipogenic glycerol-3-phosphate acyltransferase 1 gene expression in the mouse neonatal liver. Diabetes. 61:2442–2450. doi: 10.2337/db11-1834

Emberson JR, Whincup PH, Morris RW, Walker M. 2003. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: Impact of regression dilution bias. Eur Heart J. 24:1719–1726. doi: 10.1016/S0195-668X(03)00471-8

Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CRH, Shimizu T, Spener F, Van Meer G, Wakelam MJO, Dennis EA. 2009. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res. 50:S9–S14. doi: 10.1194/jlr.R800095-JLR200

Forouzanfar MH, Afshin A, Alexander LT, Biryukov S, Brauer M, Cercy K, Charlson FJ, Cohen AJ, Dandona L, Estep K, et al. 2016. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388:1659–1724. doi: 10.1016/S0140-6736(16)31679-8

Franke AA, Halm BM, Custer LJ, Tatsumura Y, Hebshi S. 2006. Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr. 84:406–413. doi: 10.1093/ajcn/84.1.406

Gomes RM, Bueno FG, Schamber CR, de Mello JCP, de Oliveira JC, Francisco FA, Moreira VM, Junior MDF, Pedrino GR, de Freitas Mathias PC, et al. 2018. Maternal diet-induced obesity during suckling period programs offspring obese phenotype and hypothalamic leptin/insulin resistance. J Nutr Biochem. 61:24– 32. doi: 10.1016/j.jnutbio.2018.07.006

Grau M, Subirana I, Elosua R, Fitó M, Covas MI, Sala J, Masiá R, Ramos R, Solanas P, Cordon F, et al. 2010. Why should population attributable fractions be periodically recalculated?. An example from cardiovascular risk estimation in southern Europe. Prev Med. 51:78–84. doi: 10.1016/j.ypmed.2010.03.012

Gregorio BM, Souza-Mello V, Carvalho JJ, Mandarim-De-Lacerda CA, Aguila MB. 2010. Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. Am J Obstet Gynecol. 203:495.e1-495.e8. doi: 10.1016/j.ajog.2010.06.042

Hachul ACL, Boldarine VT, Neto NIP, Moreno MF, Ribeiro EB, Do Nascimento CMO, Oyama LM. 2018. Maternal consumption of green tea extract during pregnancy and lactation alters offspring’s metabolism in rats. PLoS One. 13:e0199969. doi: 10.1371/journal.pone.0199969

Hanson MA, Gluckman PD. 2014. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev. 94:1027–1076. doi: 10.1152/physrev.00029.2013

Imano H, Noda H, Kitamura A, Sato S, Kiyama M, Sankai T, Ohira T, Nakamura M, Yamagishi K, Ikeda A, et al. 2011. Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: The Circulatory Risk in Communities Study (CIRCS). Prev Med. 52:381–386. doi: 10.1016/j.ypmed.2011.02.019

James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, AbdAllah F, Abdela J, Abdelalim A, et al. 2018. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7

Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 444:840–846. doi: 10.1038/nature05482

Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO. 1986. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J. 112:825–836. doi: 10.1016/0002-8703(86)90481-3

Kataoka S, Norikura T, Sato S. 2018. Maternal green tea polyphenol intake during lactation attenuates kidney injury in high-fat-diet-fed male offspring programmed by maternal protein restriction in rats. J Nutr Biochem. 56:99–108. doi: 10.1016/j.jnutbio.2018.01.012

Khymenets O, Rabassa M, Rodríguez-Palmero M, Rivero-Urgell M, Urpi-Sarda M, Tulipani S, Brandi P, Campoy C, Santos-Buelga C, Andres-Lacueva C. 2016. Dietary epicatechin is available to breastfed infants through human breast milk in the form of host and microbial metabolites. J Agric Food Chem. 64:5354– 5360. doi: 10.1021/acs.jafc.6b01947

Li S, Tse IMY, Li ETS. 2012. Maternal green tea extract supplementation to rats fed a high-fat diet ameliorates insulin resistance in adult male offspring. J Nutr Biochem. 23:1655–1660. doi: 10.1016/j.jnutbio.2011.11.008

Ludwig J, Viggiano TR, McGill DB, Ott BJ. 1980. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 55:434–438.

Ma RCW, Chan JCN. 2009. Pregnancy and diabetes scenario around the world: China. Int J Gynecol Obstet. 104:S42–S45. doi: 10.1016/j.ijgo.2008.11.032

Mahmoodi M, Hosseini R, Kazemi A, Ofori‐Asenso R, Mazidi M, Mazloomi SM. 2020. Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials. Phyther Res. 34:1587– 1598. doi: 10.1002/ptr.6637

McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. 2015. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management. J Hepatol. 62:1148–1155. doi: 10.1016/j.jhep.2014.11.034

Musial C, Kuban-Jankowska A, Gorska-Ponikowska M. 2020. Beneficial properties of green tea catechins. Int J Mol Sci. 21:1744. doi: 10.3390/ijms21051744

Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell W. 1990. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology. 11:74–80. doi: 10.1002/hep.1840110114

Reynolds RM, Allan KM, Raja EA, Bhattacharya Sohinee, McNeill G, Hannaford PC, Sarwar N, Lee AJ, Bhattacharya Siladitya, Norman JE. 2013. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: Follow-up of 1 323 275 person years. BMJ. 347:f4539. doi: 10.1136/bmj.f4539

Ribaroff GA, Wastnedge E, Drake AJ, Sharpe RM, Chambers TJG. 2017. Animal models of maternal high fat diet exposure and effects on metabolism in offspring: a meta-regression analysis. Obes Rev. 18:673–686. doi: 10.1111/obr.12524

Romaszko E, Wiczkowski W, Romaszko J, Honke J, Piskula MK. 2014. Exposure of breastfed infants to quercetin after consumption of a single meal rich in quercetin by their mothers. Mol Nutr Food Res. 58:221–228. doi: 10.1002/mnfr.201200773

Ros P, Díaz F, Freire-Regatillo A, Argente-Arizón P, Barrios V, Argente J, Chowen JA. 2018. Resveratrol Intake During Pregnancy and Lactation Modulates the Early Metabolic Effects of Maternal Nutrition Differently in Male and Female Offspring. Endocrinology. 159:810–825. doi: 10.1210/en.2017-00610

Sarker G, Berrens R, von Arx J, Pelczar P, Reik W, Wolfrum C, Peleg-Raibstein D. 2018. Transgenerational transmission of hedonic behaviors and metabolic phenotypes induced by maternal overnutrition. Transl Psychiatry. 8:195. doi: 10.1038/s41398-018-0243-2

Sarker G, Litwan K, Kastli R, Peleg-Raibstein D. 2019. Maternal overnutrition during critical developmental periods leads to different health adversities in the offspring: relevance of obesity, addiction and schizophrenia. Sci Rep. 9:17322. doi: 10.1038/s41598-019-53652-x

Sato S, Mukai Y, Hamaya M, Sun Y, Kurasaki M. 2013. Long-term effect of green tea extract during lactation on AMPK expression in rat offspring exposed to fetal malnutrition. Nutrition. 29:1152–1158. doi: 10.1016/j.nut.2013.03.021

Schaffner F, Thaler H. 1986. Nonalcoholic fatty liver disease. Prog Liver Dis. 8:283–298.

Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. 2000. Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-term Coronary, Cardiovascular, and All-Cause Mortality and to Longevity. JAMA. 284:311-318. doi: 10.1001/jama.284.3.311

Subramaniam S, Fahy E, Gupta S, Sud M, Byrnes RW, Cotter D, Dinasarapu AR, Maurya MR. 2011. Bioinformatics and systems biology of the lipidome. Chem Rev. 111:6452–6490. doi: 10.1021/cr200295k

Sugiyama D, Okamura T, Watanabe M, Higashiyama A, Okuda N, Nakamura Y, Hozawa A, Kita Y, Kadota A, Murakami Y, et al. 2015. Risk of Hypercholesterolemia for Cardiovascular Disease and the Population Attributable Fraction in a 24- year Japanese Cohort Study. J Atheroscler Thromb. 22:95–107. doi: 10.5551/jat.25908

Torres DM, Williams CD, Harrison SA. 2012. Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 10:837–858. doi: 10.1016/j.cgh.2012.03.011

Vernon G, Baranova A, Younossi ZM. 2011. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 34:274–285. doi: 10.1111/j.1365-2036.2011.04724.x

Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, Haffner SM, Saad MF, Bergman RN. 2003. Insulin sensitivity, insulin secretion, and abdominal fat: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 52:2490–2496. doi: 10.2337/diabetes.52.10.2490

Wang PX, Wang JJ, Lei YX, Xiao L, Luo ZC. 2012. Impact of Fetal and Infant Exposure to the Chinese Great Famine on the Risk of Hypertension in Adulthood. PLoS One. 7: e49720. doi: 10.1371/journal.pone.0049720

World Health Organization (WHO). 2018. Noncommunicable diseases [Internet]. [accessed 2020 Dec 15]. Available: https://www.who.int/news-room/factsheets/detail/noncommunicable-diseases

World Health Organization (WHO). 2020. Obesity and overweight [Internet]. [accessed 2020 Dec 15]. Available: https://www.who.int/news-room/factsheets/detail/obesity-and-overweight

Yajnik CS. 2010. Fetal programming of diabetes: Still so much to learn! Diabetes Care. 33:1146–1148. doi: 10.2337/dc10-0407

Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. 2018. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 15:11–20. doi: 10.1038/nrgastro.2017.109

Younossi ZM, Gramlich T, Yao CL, Matteoni C, Petrelli M, Goldblum J, Rybicki L, McCullough AJ. 1998. Nonalcoholic fatty liver disease: Assessment of variability in pathologic interpretations. Mod Pathol. 11:560–565.

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. 2016. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64:73–84. doi:10.1002/hep.28431

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る